These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3120817)

  • 1. Pituitary somatotropic and corticotropic function in patients with beta-thalassemia on iron chelation therapy.
    Tolis G; Politis C; Kontopoulou I; Poulatzas N; Rigas G; Saridakis C; Athanasiou V; Mortoglou A; Malachtari S; Ling N
    Birth Defects Orig Artic Ser; 1987; 23(5A):449-52. PubMed ID: 3120817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the secretion of GH and GH-releasing hormone (GHRH) in adolescents with thalassemia treated with chorionic gonadotropins].
    Valtorta A; Moretta A; Biscaldi I; Romano MR; Cecchi P; Gasparoni A
    Medicina (Firenze); 1988; 8(1):76-7. PubMed ID: 3147350
    [No Abstract]   [Full Text] [Related]  

  • 3. Spleen iron content is low in thalassemia.
    Borgna-Pignatti C; De Stefano P; Bongo IG; Avato F; Cazzola M
    Am J Pediatr Hematol Oncol; 1984; 6(3):340-3. PubMed ID: 6517228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of iron overload in thalassemia.
    Cianciulli P
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of T2* magnetic resonance in monitoring iron chelation therapy.
    Carpenter JP; Pennell DJ
    Acta Haematol; 2009; 122(2-3):146-54. PubMed ID: 19907152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of nicotinic acid electrophoresis on the somatotropic function of the pituitary gland].
    Reznik IP
    Vrach Delo; 1971 Jul; 7():59-60. PubMed ID: 4941615
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of acoustic stimulation on human somatotropic hormone secretion].
    Favino A; Scoz R; Trecate G
    Boll Soc Ital Biol Sper; 1971 Nov; 47(21):704-8. PubMed ID: 5147580
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principles of treatment with iron chelates].
    Gershko Kh; Link D; Pinson A
    Gematol Transfuziol; 1990 Mar; 35(3):13-5. PubMed ID: 2361582
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of iron in osteoporosis.
    Weinberg ED
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():81-5. PubMed ID: 19337160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of the epiphysis on the somatotropic function of the pituitary].
    Grachev II; Usanova RI; Seliverstov IuA
    Fiziol Zh SSSR Im I M Sechenova; 1972 Feb; 58(2):272-5. PubMed ID: 5019524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on the secretion of the somatotropic hormone during the 1st month of life].
    Massi-Benedetti F; Gallo G; Barboni G; Falorni A
    Minerva Pediatr; 1976 May; 28(18):1136-8. PubMed ID: 796652
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.
    Porter JB; Davis BA
    Best Pract Res Clin Haematol; 2002 Jun; 15(2):329-68. PubMed ID: 12401311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of the secretion of growth hormone in patients with thalassemia major].
    De Luca G; Maggiolini M; Bria M; Caracciolo M; Lanzino M; Le Pera M; Brancati C; Andò S
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):62-5. PubMed ID: 7910656
    [No Abstract]   [Full Text] [Related]  

  • 14. Computed tomography scanning of the liver to determine efficacy of iron chelation therapy in thalassemia major.
    Olivieri NF; Grisaru D; Daneman A; Martin DJ; Rose V; Freedman MH
    J Pediatr; 1989 Mar; 114(3):427-30. PubMed ID: 2921687
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between sleep and growth hormone. Evaluated by manual polysomnography and automatic power spectrum analysis.
    Aström C
    Acta Neurol Scand; 1995 Oct; 92(4):281-96. PubMed ID: 8848933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 17. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ; Kartikasari AE; Georgiou NA
    Hemoglobin; 2008; 32(1-2):123-34. PubMed ID: 18274990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of parameters for a mathematical model of growth hormone secretion.
    Brown D; Stephens EA; Smith RG; Li G; Leng G
    J Neuroendocrinol; 2004 Nov; 16(11):936-46. PubMed ID: 15584935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of new drugs for use in iron chelation therapy.
    Grady RW
    Birth Defects Orig Artic Ser; 1976; 12(8):161-75. PubMed ID: 795480
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothalamic and thyroidal regulation of growth hormone in tilapia.
    Melamed P; Eliahu N; Levavi-Sivan B; Ofir M; Farchi-Pisanty O; Rentier-Delrue F; Smal J; Yaron Z; Naor Z
    Gen Comp Endocrinol; 1995 Jan; 97(1):13-30. PubMed ID: 7713377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.